Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥189.90 - CN¥284.34
Next Earnings Date
Apr 26 2025
Next Earnings Date
Apr 26 2025
Latest price
Market Cap | CN¥123.70B |
EV | CN¥122.18B |
Shares Outstanding | 603.32M |
Beta | 1.00 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CN¥267.08 |
P/E 2025E | 36.16x |
P/Revenue 2025E | 10.27x |
Revenue | 10.30% |
EPS | 7.00% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 17.90% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 47.46% |
Net Profit Margin 2025E | 28.39% |
ROE 2025E | 21.23% |
ROCE 2024 | 21.71% |
DPS 2025E | CN¥2.02 |
Payout Ratio 2025E | 35.63% |
Div. Yield 2025E | 0.99% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Zhangzhou Pientzehuang Pharmaceutical., Ltd
600436
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Huang, Jin Ming
Employees
2,789
Website
www.zzpzh.com.cnIPO Date
2003-06-16
Headquarters
No. 1 Hupo Road, Xiangcheng District, Zhangzhou, Fujian Province, 363000, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved